Prominin-1 (CD133) Defines Both Stem and Non-Stem Cell Populations in CNS Development and Gliomas

Karl Holmberg Olausson; Cecile L. Maire; Sam Haidar; Jason Ling; Emily Learner; Monica Nistér; Keith L. Ligon

doi:10.1371/journal.pone.0106694

Loading metrics

Open Access

Peer-reviewed

Research Article

Prominin-1 (CD133) Defines Both Stem and Non-Stem Cell Populations in CNS Development and Gliomas

Karl Holmberg Olausson ,

Contributed equally to this work with: Karl Holmberg Olausson, Cecile L. Maire

Affiliations Center for Molecular Oncologic Pathology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Oncology Pathology, Karolinska Institutet, Stockholm, Sweden
⨯
Cecile L. Maire ,

Contributed equally to this work with: Karl Holmberg Olausson, Cecile L. Maire

Affiliation Center for Molecular Oncologic Pathology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Sam Haidar,

Affiliation Center for Molecular Oncologic Pathology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Jason Ling,

Affiliation Center for Molecular Oncologic Pathology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Emily Learner,

Affiliation Center for Molecular Oncologic Pathology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Monica Nistér,

Affiliation Department of Oncology Pathology, Karolinska Institutet, Stockholm, Sweden
⨯
Keith L. Ligon

* E-mail: keith_ligon@dfci.harvard.edu

Affiliations Center for Molecular Oncologic Pathology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America
⨯

Prominin-1 (CD133) Defines Both Stem and Non-Stem Cell Populations in CNS Development and Gliomas

Karl Holmberg Olausson,
Cecile L. Maire,
Sam Haidar,
Jason Ling,
Emily Learner,
Monica Nistér,
Keith L. Ligon

Published: September 3, 2014
https://doi.org/10.1371/journal.pone.0106694

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Central nervous system
Is the Subject Area "Central nervous system" applicable to this article?

Thanks for your feedback.
Immunohistochemistry techniques
Is the Subject Area "Immunohistochemistry techniques" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Stem cells
Is the Subject Area "Stem cells" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Cell staining
Is the Subject Area "Cell staining" applicable to this article?

Thanks for your feedback.
Corpus callosum
Is the Subject Area "Corpus callosum" applicable to this article?

Thanks for your feedback.
Neural stem cells
Is the Subject Area "Neural stem cells" applicable to this article?

Thanks for your feedback.